MLAB
Mesa Laboratories, Inc. NASDAQ$102.99
Mkt Cap $569.0M
52w Low $55.45
62.8% of range
52w High $131.20
50d MA $91.10
200d MA $79.42
P/E (TTM)
-287.0x
EV/EBITDA
18.9x
P/B
3.5x
Debt/Equity
1.1x
ROE
1.8%
P/FCF
15.2x
RSI (14)
—
ATR (14)
—
Beta
0.89
50d MA
$91.10
200d MA
$79.42
Avg Volume
111.5K
About
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection proce…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | AMC | 1.40 | 3.07 | +119.3% | 87.53 | +1.8% | +4.6% | +4.2% | +6.6% | +3.7% | +5.0% | — |
| Nov 6, 2025 | AMC | 1.56 | 1.76 | +12.8% | 74.87 | +1.3% | +1.5% | +9.3% | +6.9% | +6.7% | +1.3% | — |
| Aug 5, 2025 | AMC | 2.46 | 2.32 | -5.7% | 57.44 | +0.6% | +8.0% | +10.5% | +11.9% | +5.3% | +10.1% | — |
| May 28, 2025 | AMC | 2.75 | 2.23 | -18.9% | 103.07 | +0.7% | +1.5% | -2.4% | -5.0% | -2.9% | -2.1% | — |
| Feb 4, 2025 | AMC | 1.41 | 2.67 | +89.4% | 137.27 | +1.4% | +1.2% | +3.2% | +7.7% | +12.7% | +9.6% | — |
| Nov 7, 2024 | AMC | 2.48 | 2.45 | -1.2% | 117.89 | +0.1% | +0.8% | +0.9% | -4.7% | -8.6% | -11.3% | — |
| Aug 5, 2024 | AMC | 2.33 | 2.83 | +21.5% | 104.71 | +2.7% | +8.0% | +13.6% | +22.5% | +14.2% | +11.9% | — |
| Jun 5, 2024 | AMC | -0.11 | 2.77 | +2618.2% | 107.20 | -1.0% | +0.1% | -2.2% | -6.8% | -10.8% | -11.0% | — |
| Feb 5, 2024 | AMC | 2.04 | 2.02 | -1.0% | 99.30 | -0.2% | -3.4% | -8.7% | -6.0% | -5.5% | -4.0% | — |
| Nov 6, 2023 | AMC | 1.65 | 1.91 | +15.8% | 91.91 | -1.9% | +1.5% | +2.0% | -6.8% | -7.5% | -8.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $87.53 | $89.07 | +1.8% | +4.6% | +4.2% | +6.6% | +3.7% | +5.0% |
| Dec 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $77.77 | $78.48 | +0.9% | +0.1% | +1.1% | +2.6% | +3.6% | +4.2% |
| Aug 8 | Wells Fargo | Upgrade | Underweight → Equal Weight | — | $63.47 | $63.28 | -0.3% | +1.3% | -4.7% | -0.3% | +9.2% | +7.0% |
| May 30 | Wells Fargo | Maintains | Underweight → Underweight | — | $104.64 | $102.75 | -1.8% | -3.8% | -6.4% | -4.3% | -3.5% | -4.6% |
| Oct 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $129.86 | $129.34 | -0.4% | +0.4% | +1.9% | +0.6% | +2.9% | -2.2% |
| Aug 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $104.71 | $107.50 | +2.7% | +8.0% | +13.6% | +22.5% | +14.2% | +11.9% |
| Jul 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $88.45 | $87.54 | -1.0% | -0.8% | +2.2% | +3.4% | +7.6% | +4.9% |
| Apr 4 | Evercore ISI | Maintains | Outperform → Outperform | — | $99.80 | $102.17 | +2.4% | +0.4% | +1.1% | +6.4% | +7.1% | +4.3% |
| Jan 4 | Evercore ISI | Upgrade | In Line → Outperform | — | $97.13 | $99.00 | +1.9% | +3.6% | +1.9% | +5.6% | +5.0% | +2.8% |
| Jan 4 | Evercore ISI | Downgrade | Outperform → In Line | — | $286.64 | $285.12 | -0.5% | -2.6% | -2.0% | +0.9% | +1.7% | +1.1% |
Recent Filings
8-K
Unknown — 8-K Filing
A board member's departure without operational disagreement suggests routine leadership transition, reducing governance risk concerns but potentially signaling planned strategic shifts investors should monitor.
Mar 23
8-K · 5.02
!!! Very High
Mesa Laboratories Inc -- 8-K 5.02: Executive Change
Mesa Laboratories appoints Dr. Siddhartha Kadia as President following Owens' resignation, signaling leadership transition that investors should monitor for strategic direction changes.
Mar 9
8-K
Mesa Laboratories Inc -- 8-K Filing
Mesa Laboratories reported third quarter fiscal 2026 results ending December 31, 2025, demonstrating operational performance for the life science tools and quality control solutions provider.
Feb 3
Data updated apr 26, 2026 12:30pm
· Source: massive.com